Avastin, also known as bevacizumab, is a cancer medicine used in the treatment of recurrent glioblastoma in adults.

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

A simple blood test identified women at higher risk for dementia up to 25 years before symptoms appeared. Higher levels of ...

Two-year data from Eli Lilly’s SURPASS-EARLY trial show reduced A1c, body weight, and cardiovascular risk factors.

Biogen’s salanersen is now heading into three Phase III trials in SMA.

Zealand Pharma plans to open a new research facility in Boston, part of the obesity drugmaker’s effort to expand its presence in the US. The Danish company will likely hire between 50 and 100 people ...

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, today announced the ...

Pope Leo XIV has named Spanish Augustinian Bishop Luis Marín de San Martín as the new prefect of the Dicastery for the Service of Charity, reassigning Cardinal Konrad Krajewski to serve as archbishop ...

Data protection gaps persist in real-time retrieval and revenue-driving search LOS ANGELES, March 12, 2026 /PRNewswire/ -- SearchStax, Inc., the Search Experience Company, today introduced a defined ...

This report is tailored for C-level executives, business development professionals, licensing managers, legal advisors, and anyone involved in pharmaceutical and biotechnology deal-making. It provides ...

Pope Leo XIV has named Spanish Augustinian Bishop Luis Marín de San Martín as the new prefect of the Dicastery for the Service of Charity.

Halozyme Therapeutics, Inc. ("Halozyme" or the "Company") today announced that David Ramsay has been appointed Interim Chief Financial Officer (CFO), effective March 23, 2026. Mr. Ramsay will oversee ...